-
1دورية أكاديمية
المؤلفون: Mallampalli, Monica P., Huyer, Gregory, Bendale, Pravin, Gelb, Michael H., Michaelis, Susan, Greider, Carol W.
المصدر: Proceedings of the National Academy of Sciences of the United States of America, 2005 Oct 01. 102(40), 14416-14421.
URL الوصول: https://www.jstor.org/stable/3376753
-
2دورية أكاديمية
المؤلفون: Kirschbaum, M HAff1, IDleu2011124_cor1, Synold, T, Stein, A S, Tuscano, J, Zain, J M, Popplewell, L, Karanes, C, O'Donnell, M R, Pulone, B, Rincon, A, Wright, J, Frankel, P, Forman, S J, Newman, E M
المصدر: Leukemia. 25(10):1543-1547
-
3دورية أكاديمية
المؤلفون: Jawad Mays, Yu Ning, Seedhouse Claire, Tandon Karuna, Russell Nigel H, Pallis Monica
المصدر: BMC Cancer, Vol 12, Iss 1, p 431 (2012)
مصطلحات موضوعية: Tipifarnib/Zarnestra, Gemtuzumab ozogamicin/ Mylotarg, AML CD34+CD38- cells, DNA damage response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4
المؤلفون: Joseph Tuscano, Jasmine Zain, Timothy W. Synold, John J. Wright, Bernadette Pulone, Stephen J. Forman, Margaret R. O'Donnell, Edward M. Newman, Paul Frankel, Amalia Rincon, Anthony S. Stein, Mark Kirschbaum, Leslie Popplewell, Chatchada Karanes
المصدر: Leukemia, vol 25, iss 10
Leukemiaمصطلحات موضوعية: Oncology, Male, Myeloid, Cancer Research, Pharmacology, Quinolones, 0302 clinical medicine, phase 1 trial, AML, Recurrence, Risk Factors, Cancer, Pediatric, 0303 health sciences, Leukemia, Myeloid leukemia, Hematology, Middle Aged, 3. Good health, Leukemia, Myeloid, Acute, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Zarnestra®, Female, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Childhood Leukemia, Pediatric Cancer, acute myelogenous leukemia, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Immunology, Antineoplastic Agents, Acute, Article, 03 medical and health sciences, Myelogenous, Rare Diseases, Pharmacokinetics, Refractory, In vivo, Clinical Research, Internal medicine, medicine, Humans, 030304 developmental biology, Aged, business.industry, tipifarnib, Evaluation of treatments and therapeutic interventions, medicine.disease, Clinical trial, farnesyltransferase, Tipifarnib, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c0c3328e8ef6e61e7950adfbd06f9b
https://escholarship.org/uc/item/1jh25821 -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Monica Pallis, Claire Seedhouse, Mays Jawad, Nigel H. Russell, Ning Yu, Karuna Tandon
المصدر: BMC Cancer, Vol 12, Iss 1, p 431 (2012)
BMC Cancerمصطلحات موضوعية: Cancer Research, Myeloid, Gemtuzumab ozogamicin, Sialic Acid Binding Ig-like Lectin 3, Interleukin-3 Receptor alpha Subunit, CD34, Antigens, CD34, Antineoplastic Agents, Quinolones, CD38, Biology, Antibodies, Monoclonal, Humanized, DNA damage response, lcsh:RC254-282, Histones, AML CD34+CD38- cells, Cell Line, Tumor, hemic and lymphatic diseases, medicine, Genetics, Humans, ATP Binding Cassette Transporter, Subfamily B, Member 1, Tipifarnib/Zarnestra, Cell Proliferation, Nuclear Proteins, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, ADP-ribosyl Cyclase 1, Gemtuzumab, Gemtuzumab ozogamicin/ Mylotarg, Leukemia, Myeloid, Acute, Leukemia, Aminoglycosides, medicine.anatomical_structure, fms-Like Tyrosine Kinase 3, Oncology, Drug Resistance, Neoplasm, Fms-Like Tyrosine Kinase 3, Monoclonal, Neoplastic Stem Cells, Cancer research, Tipifarnib, Nucleophosmin, Research Article, DNA Damage, Signal Transduction, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e786cefd3d1f6138d63ff8aa3e2c682
Full Text Finder 
Find this article in full text from Springer Verlag.